{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:29:37Z","timestamp":1793636977987,"version":"4.5.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA275036"],"award-info":[{"award-number":["R01CA275036"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neo.2026.101379","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:58:23Z","timestamp":1791547103000},"page":"101379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"82","author":[{"given":"Hannah R.","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Podgorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique R.","family":"Archuleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4423-2810","authenticated-orcid":false,"given":"Atsushi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2943-5708","authenticated-orcid":false,"given":"Aaron","family":"Ramonett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8722-9187","authenticated-orcid":false,"given":"Christopher","family":"Cartmell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4231-502X","authenticated-orcid":false,"given":"Nathan A.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1929-737X","authenticated-orcid":false,"given":"Paul R.","family":"Langlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-0098","authenticated-orcid":false,"given":"Karthikeyan","family":"Mythreye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-8783","authenticated-orcid":false,"given":"Nadine","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-0774","authenticated-orcid":false,"given":"Nam Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2026.101379_bib0001","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.molmed.2024.03.008","article-title":"Exploiting pancreatic cancer metabolism: challenges and opportunities","volume":"30","author":"De Santis","year":"2024","journal-title":"Trends. Mol. Med."},{"key":"10.1016\/j.neo.2026.101379_bib0002","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.neo.2026.101379_bib0003","doi-asserted-by":"crossref","first-page":"688","DOI":"10.20892\/j.issn.2095-3941.2019.0252","article-title":"The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview","volume":"16","author":"Quinonero","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.neo.2026.101379_bib0004","doi-asserted-by":"crossref","first-page":"799","DOI":"10.32604\/or.2024.045356","article-title":"Targeting KRAS in pancreatic cancer","volume":"32","author":"Stickler","year":"2024","journal-title":"Oncol. Res."},{"issue":"386\u2013402","key":"10.1016\/j.neo.2026.101379_bib0005","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neo.2026.101379_bib0006","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1158\/1078-0432.CCR-10-0248","article-title":"Serum biomarker panels for the detection of pancreatic cancer","volume":"17","author":"Brand","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101379_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-4682-11-34","article-title":"Prospects for developing an accurate diagnostic biomarker panel for low prevalence cancers","volume":"11","author":"Firpo","year":"2014","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.neo.2026.101379_bib0008","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.CCR-19-1496","article-title":"The proteomic landscape of pancreatic ductal adenocarcinoma liver metastases identifies molecular subtypes and associations with clinical response","volume":"26","author":"Law","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101379_bib0009","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.284.5419.1534","article-title":"Defective angiogenesis in mice lacking endoglin","volume":"284","author":"Li","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neo.2026.101379_bib0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neo.2026.101379_bib0011","doi-asserted-by":"crossref","first-page":"25486","DOI":"10.1074\/jbc.M114.578609","article-title":"Src-mediated post-translational regulation of endoglin stability and function is critical for angiogenesis","volume":"289","author":"Pan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2026.101379_bib0012","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jcb.21594","article-title":"Novel biochemical pathways of endoglin in vascular cell physiology","volume":"102","author":"Bernabeu","year":"2007","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.neo.2026.101379_bib0013","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s43856-023-00347-0","article-title":"Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial","volume":"3","author":"Ahluwalia","year":"2023","journal-title":"Commun. Med."},{"key":"10.1016\/j.neo.2026.101379_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clgc.2016.05.010","article-title":"A phase II clinical trial of TRC105 (Anti-Endoglin Antibody) in adults with advanced\/metastatic urothelial carcinoma","volume":"15","author":"Apolo","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.neo.2026.101379_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvp332","article-title":"Targeting cancer vasculature via endoglin\/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours","volume":"86","author":"Fonsatti","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neo.2026.101379_bib0016","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-09-4466","article-title":"Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis","volume":"70","author":"Hawinkels","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101379_bib0017","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1038\/onc.2013.386","article-title":"Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-beta signaling","volume":"33","author":"Kumar","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2026.101379_bib0018","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/1535-7163.MCT-14-0291","article-title":"Inhibition of endoglin-GIPC interaction inhibits pancreatic cancer cell growth","volume":"13","author":"Pal","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neo.2026.101379_bib0019","first-page":"2651","article-title":"Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer","volume":"31","author":"Landt","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.neo.2026.101379_bib0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13277-011-0157-6","article-title":"Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status","volume":"32","author":"Bock","year":"2011","journal-title":"Tumour. Biol."},{"key":"10.1016\/j.neo.2026.101379_bib0021","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/onc.2010.488","article-title":"Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome","volume":"30","author":"Henry","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2026.101379_bib0022","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/ijms22063186","article-title":"Endoglin in the spotlight to treat cancer","volume":"22","author":"Gonzalez Munoz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2026.101379_bib0023","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11010-021-04294-z","article-title":"The role of endoglin and its soluble form in pathogenesis of preeclampsia","volume":"477","author":"Margioula-Siarkou","year":"2022","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.neo.2026.101379_bib0024","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/ijms22010147","article-title":"Endoglin targeting: lessons learned and questions that remain","volume":"22","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2026.101379_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102297","article-title":"EPDR1 is a noncanonical effector of insulin-mediated angiogenesis regulated by an endothelial-specific TGF-beta receptor complex","volume":"298","author":"Ahmed","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.neo.2026.101379_bib0026","article-title":"Genetically engineered mouse models of pancreatic cancer: the KPC model (LSL-Kras(G12D\/+);LSL-Trp53(R172H\/+);pdx-1-cre), its variants, and their application in immuno-oncology drug discovery","volume":"73","author":"Lee","year":"2016","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.neo.2026.101379_bib0027","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer. Cell."},{"key":"10.1016\/j.neo.2026.101379_bib0028","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E23-02-0064","article-title":"Endothelial tip\/stalk cell selection requires BMP9-induced beta(IV)-spectrin expression during sprouting angiogenesis","volume":"34","author":"Ahmed","year":"2023","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neo.2026.101379_bib0029","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1084\/jem.20120662","article-title":"Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination","volume":"210","author":"Anderberg","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neo.2026.101379_bib0030","doi-asserted-by":"crossref","first-page":"14884","DOI":"10.1074\/jbc.M114.630178","article-title":"Endoglin regulation of Smad2 function mediates Beclin1 expression and endothelial autophagy","volume":"290","author":"Pan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2026.101379_bib0031","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.3390\/cancers15235689","article-title":"Pan-cancer profiling of intron retention and its clinical significance in diagnosis and prognosis","volume":"15","author":"Huang","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2026.101379_bib0032","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41525-020-00159-4","article-title":"Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma","volume":"5","author":"Tan","year":"2020","journal-title":"NPJ. Genom. Med."},{"key":"10.1016\/j.neo.2026.101379_bib0033","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccell.2017.09.005","article-title":"Exploiting the hidden treasure of detained introns","volume":"32","author":"Fu","year":"2017","journal-title":"Cancer. Cell"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626001119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626001119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:18:07Z","timestamp":1793636287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626001119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S1476558626001119"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101379","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101379"}}